17-Nov-2026 10:12:14
SAIPARENT: SP ANALYTICS STEP-DOWN SUBSIDIARY ACQUIRES MAJORITY STAKE IN BION THERAPEUTICS
• SP Analytics Private Limited signed a definitive agreement to acquire a majority stake in Bion Therapeutics India Private Limited • Bion is a Hyderabad-based branded formulations prescription business with 16 branded formulations and around 250 field staff • Bion covers 12 states, around 20,000 doctors and over 17,000 retailers across neuropathy, diabetes supportive care, mitochondrial health, wound care and pain management • Bion will become a step-down subsidiary of Sai Parenterals on completion, expected before the end of this month; transaction is all-cash • Deal to be funded through internal accruals, debt and a portion of the IPO proceeds allocated to general corporate purposes • Post acquisition, Bion’s contract-manufactured portfolio will progressively move to Sai Parenterals’ TGA-Australia and WHO-GMP accredited facilities
Sai Parenterals Ltd
Open attachment